T L Phillips. Show Affiliations »
Abstract
Mesh: See more » Alkylating Agents/therapeutic useAmifostine/adverse effectsAmifostine/therapeutic useAnimalsDrug SynergismHumansMiceMisonidazole/adverse effectsMisonidazole/therapeutic useNeoplasms/drug therapyNeoplasms/radiotherapyNeoplasms, Experimental/drug therapyNeoplasms, Experimental/radiotherapyNitroimidazoles/therapeutic useOrganothiophosphorus Compounds/therapeutic useRadiation-Protective Agents/adverse effectsRadiation-Protective Agents/therapeutic useRadiation-Sensitizing Agents/adverse effectsRadiation-Sensitizing Agents/therapeutic use
Substances: See more » Alkylating AgentsNitroimidazolesOrganothiophosphorus CompoundsRadiation-Protective AgentsRadiation-Sensitizing AgentsMisonidazoleAmifostine
Year: 1981 PMID: 6264627
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929